Stopping weight loss drugs doubles heart attack risk in diabetics
Audio narration · Coming soon
A study analyzing over 80,000 patients in Italy found that diabetics who discontinued GLP-1 weight loss medications experienced twice the risk of heart attacks compared to those who continued the treatment. This research highlights the cardiovascular benefits of maintaining GLP-1 medication in diabetic patients.
Why this matters
PRISM scored this story 65/100 for interest.
Originally published by gnews
